Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Indaptus Therapeutics
INDP
$334M
| $313K | ﹤0.01% |
493
+369
| +298% | +$228K |
2020 Q1
1 quarter
|
|
|
SUMR
3027
DELISTED
Summer Infant, Inc.
SUMR
| $313K | ﹤0.01% |
38,999
-1,524
| -4% | -$6.79K |
2013 Q2
28 quarters
|
|
3028
Live Ventures
LIVE
$23.5M
| $312K | ﹤0.01% |
32,799
+4,736
| +17% | +$37.1K |
2019 Q3
3 quarters
|
|
|
MOGU
3029
MOGU Inc
MOGU
$18.3M
| $311K | ﹤0.01% |
14,375
+10,783
| +300% | +$165K |
2019 Q2
4 quarters
|
|
3030
Movado Group
MOV
$704M
| $310K | ﹤0.01% |
+28,598
| New | +$309K |
2020 Q2
0 quarters
|
|
|
RNDB
3031
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
| $310K | ﹤0.01% |
30,892
+9,692
| +46% | +$91.7K |
2019 Q4
2 quarters
|
|
|
CBAY
3032
DELISTED
Cymabay Therapeutics
CBAY
| $309K | ﹤0.01% |
+88,520
| New | +$255K |
2020 Q2
0 quarters
|
|
|
AXIA
3033
DELISTED
AXIA Energia
AXIA
| $306K | ﹤0.01% |
68,193
-1,151,961
| -94% | -$4.5M |
2019 Q1
5 quarters
|
|
|
SDEV
3034
Stablecoin Development Corp
SDEV
$77.9M
| $306K | ﹤0.01% |
43
+31
| +258% | +$174K |
2018 Q3
7 quarters
|
|
3035
Wolverine World Wide
WWW
$1.59B
| $305K | ﹤0.01% |
12,800
-312,500
| -96% | -$6.35M |
2020 Q1
1 quarter
|
|
3036
Gray Media Inc
GTN.A
$518M
| $304K | ﹤0.01% |
23,400
-400
| -2% | -$5.17K |
2013 Q2
28 quarters
|
|
3037
First Internet Bancorp
INBK
$227M
| $304K | ﹤0.01% |
18,301
-62,700
| -77% | -$983K |
2019 Q3
3 quarters
|
|
3038
Aemetis
AMTX
$120M
| $303K | ﹤0.01% |
+374,807
| New | +$272K |
2020 Q2
0 quarters
|
|
3039
S&T Bancorp
STBA
$1.69B
| $303K | ﹤0.01% |
12,936
-21,564
| -63% | -$522K |
2018 Q1
9 quarters
|
|
3040
AGM Group Holdings
AGMH
$1.9M
| $302K | ﹤0.01% |
+232
| New | +$234K |
2020 Q2
0 quarters
|
|
3041
Optical Cable Corp
OCC
$140M
| $301K | ﹤0.01% |
120,303
+4,900
| +4% | +$12.4K |
2013 Q2
28 quarters
|
|
|
IHC
3042
DELISTED
Independence Holding Company
IHC
| $300K | ﹤0.01% |
+9,800
| New | +$274K |
2020 Q2
0 quarters
|
|
3043
vTv Therapeutics
VTVT
$123M
| $299K | ﹤0.01% |
3,319
-4,063
| -55% | -$401K |
2019 Q4
2 quarters
|
|
3044
Invesco CEF Income Composite ETF
PCEF
$780M
| $298K | ﹤0.01% |
+15,000
| New | +$286K |
2020 Q2
0 quarters
|
|
|
AGPU
3045
Axe Compute Inc
AGPU
$135M
| $298K | ﹤0.01% |
+606
| New | +$283K |
2020 Q2
0 quarters
|
|
|
CBMB
3046
DELISTED
CBM Bancorp, Inc.
CBMB
| $296K | ﹤0.01% |
24,105
+4,802
| +25% | +$57.4K |
2019 Q3
3 quarters
|
|
3047
Equillium
EQ
$89.4M
| $295K | ﹤0.01% |
100,149
+39,702
| +66% | +$113K |
2019 Q4
2 quarters
|
|
3048
Gevo
GEVO
$326M
| $295K | ﹤0.01% |
372,124
-204,409
| -35% | -$222K |
2017 Q4
10 quarters
|
|
3049
Riot Platforms
RIOT
$6.34B
| $295K | ﹤0.01% |
132,952
-200,949
| -60% | -$359K |
2020 Q1
1 quarter
|
|
|
SANW
3050
DELISTED
S&W Seed Co
SANW
| $294K | ﹤0.01% |
6,789
+4,132
| +156% | +$163K |
2019 Q1
5 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.